Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Desmoid Tumors × 4-hydroxy-N-desmethyltamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1 Breast 1

Conditions

Uterine Neoplasms 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Breast Neoplasms 1

Interventions

liposomal doxorubicin 1 entinostat 1 Imatinib Mesylate 1 E-7386 1 Cyclophosphamide 1 Blood Specimen Collection 1 4-hydroxy-N-desmethyltamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01273168 2025-12-23

Endoxifen in Adults With Hormone Receptor Positive Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

BreastGynecologicSarcoma

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡